Stilbenoids	O
remodel	O
the	O
DNA	O
methylation	O
patterns	O
in	O
breast	O
cancer	O
cells	O
and	O
inhibit	O
oncogenic	O
NOTCH	O
signaling	O
through	O
epigenetic	O
regulation	O
of	O
MAML2	O
transcriptional	O
activity	O
.	O


DNA	O
hypomethylation	O
was	O
previously	O
implicated	O
in	O
cancer	O
progression	O
and	O
metastasis	O
.	O


The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
examine	O
whether	O
stilbenoids	O
,	O
resveratrol	O
and	O
pterostilbene	O
thought	O
to	O
exert	O
anticancer	O
effects	O
,	O
target	O
genes	O
with	O
oncogenic	O
function	O
for	O
de	O
novo	O
methylation	O
and	O
silencing	O
,	O
leading	O
to	O
inactivation	O
of	O
related	O
signaling	O
pathways	O
.	O


Following	O
Illumina	O
450K	O
,	O
genome	O
-	O
wide	O
DNA	O
methylation	O
analysis	O
reveals	O
that	O
stilbenoids	O
alter	O
DNA	O
methylation	O
patterns	O
in	O
breast	O
cancer	O
cells	O
.	O


On	O
average	O
,	O
75	O
%	O
of	O
differentially	O
methylated	O
genes	O
have	O
increased	O
methylation	O
,	O
and	O
these	O
genes	O
are	O
enriched	O
for	O
oncogenic	O
functions	O
,	O
including	O
NOTCH	O
signaling	O
pathway	O
.	O


MAML2	O
,	O
a	O
coactivator	O
of	O
NOTCH	O
targets	O
,	O
is	O
methylated	O
at	O
the	O
enhancer	B-ENHANCER
region	E-ENHANCER
and	O
transcriptionally	O
silenced	O
in	O
response	O
to	O
stilbenoids	O
,	O
possibly	O
explaining	O
the	O
downregulation	O
of	O
NOTCH	O
target	O
genes	O
.	O


The	O
increased	O
DNA	O
methylation	O
at	O
MAML2	B-ENHANCER
enhancer	E-ENHANCER
coincides	O
with	O
increased	O
occupancy	O
of	O
repressive	O
histone	O
marks	O
and	O
decrease	O
in	O
activating	O
marks	O
.	O


This	O
condensed	O
chromatin	O
structure	O
is	O
associated	O
with	O
binding	O
of	O
DNMT3B	O
and	O
decreased	O
occupancy	O
of	O
OCT1	O
transcription	O
factor	O
at	O
MAML2	B-ENHANCER
enhancer	E-ENHANCER
,	O
suggesting	O
a	O
role	O
of	O
DNMT3B	O
in	O
increasing	O
methylation	O
of	O
MAML2	O
after	O
stilbenoid	O
treatment	O
.	O


Our	O
results	O
deliver	O
a	O
novel	O
insight	O
into	O
epigenetic	O
regulation	O
of	O
oncogenic	O
signals	O
in	O
cancer	O
and	O
provide	O
support	O
for	O
epigenetic	O
-	O
targeting	O
strategies	O
as	O
an	O
effective	O
anticancer	O
approach	O
.	O
